<DOC>
	<DOCNO>NCT00407160</DOCNO>
	<brief_summary>Comparison Campath induction monotherapy Tacrolimus v Thymoglobulin induction triple drug maintenance use Tacrolimus , mycophenolate , steroid .</brief_summary>
	<brief_title>A Trial Tolerogenic Immunosuppression Highly Sensitized Renal Transplant Recipients</brief_title>
	<detailed_description>Recent report suggest might possible induce state tolerance solid organ transplantation . So call `` tolerogenic immunosuppression '' involve induction lymphocyte deplete antibody follow monotherapy calcineurin inhibitor , cyclosporin tacrolimus . The propose study aim evaluate protocol immunosuppression induction lymphocyte deplete antibody Campath give prior graft reperfusion , follow tacrolimus monotherapy highly sensitized patient ( PRA &gt; 14 % past historical =/ &gt; 50 % and/or multiple renal transplant ) undergo renal transplantation , compare current standard protocol UTMB employ induction Thymoglobulin give 4 day follow 3 drug : tacrolimus , mycophenolate steroid . In group patient target tacrolimus level i.e , 10 15ng/mL , soon transplant . In Campath gro , tacrolimus taper 3 month patient rejection appear develop donor specific tolerance .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>1 . Males female age 1875 year . 2 . Recipients multiple kidney transplant 3 . Patients PRA &gt; 14 % and/or past historical PRA great equal 50 % . 4 . Females childbearing potential must negative pregnancy test prior inclusion . 5 . Patients willing able participate full course study write informed consent obtain . 1 . Patients history malignancy within last 5 year , except excise squamous basal cell carcinoma skin . 2 . Pregnant nursing ( lactate ) woman , pregnancy define state female contraception termination gestation , confirm positive hCG laboratory test . 3 . Patients HIV positive . 4 . Patients symptoms significant somatic mental illness evidence current drug and/or alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Kidney transplant</keyword>
	<keyword>Tolerance induction</keyword>
	<keyword>High PRA kidney recipient</keyword>
</DOC>